Kenneth Kovan
Founder at BIOVAXYS TECHNOLOGY CORP.
Net worth: 514 700 $ as of 2024-02-28
Profile
Kenneth E.
Kovan founded BioVaxys Technology Corp., AVAX Technologies, Inc. and BioVaxys LLC.
Currently, he occupies the position of President of Chaperone Technologies, Inc. and President & Chief Operating Officer for BioVaxys Technology Corp., President & Chief Operating Officer for BioVaxys LLC (a subsidiary of BioVaxys Technology Corp.).
He is also Managing Principal & Owner at Bingham Hill Ventures.
Mr. Kovan previously was Principal at GSK Plc, Principal at Wyeth-Ayerst Research, Partner at Horizon Discovery Ltd.
and Principal at Thomas Jefferson University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
BIOVAXYS TECHNOLOGY CORP
5.07% | 2024-01-25 | 7,352,862 ( 5.07% ) | 514 700 $ | 2024-02-28 |
Kenneth Kovan active positions
Companies | Position | Start |
---|---|---|
BIOVAXYS TECHNOLOGY CORP. | Founder | - |
Chaperone Technologies, Inc.
Chaperone Technologies, Inc. Medical SpecialtiesHealth Technology Chaperone Technologies, Inc. develops novel products for infectious diseases. The firm develops and produces peptide-based antimicrobial products to treat infectious diseases. The company was founded by Michael and Elisabeth Lang in March 2014 and is headquartered in Bogart, GA. | President | - |
BioVaxys LLC
BioVaxys LLC BiotechnologyHealth Technology BioVaxys LLC is a clinical stage biotechnology company, which engages in the development of immunotherapeutic vaccines for antiviral and individualized cancer therapy. It focuses on multihaptenized autologous vaccine that will initially be developed and marketed for melanoma and ovarian cancer. The company was founded by James Passin, Kenneth Kovan and David Berd and is headquartered in New York, NY. | Founder | - |
Bingham Hill Ventures | Corporate Officer/Principal | - |
Former positions of Kenneth Kovan
Companies | Position | End |
---|---|---|
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Wyeth-Ayerst Research | Corporate Officer/Principal | - |
GSK PLC | Corporate Officer/Principal | - |
Thomas Jefferson University | Corporate Officer/Principal | - |
AVAX TECHNOLOGIES, INC. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
AVAX TECHNOLOGIES, INC. | Health Technology |
GSK PLC | Health Technology |
Private companies | 6 |
---|---|
Wyeth-Ayerst Research | |
Chaperone Technologies, Inc.
Chaperone Technologies, Inc. Medical SpecialtiesHealth Technology Chaperone Technologies, Inc. develops novel products for infectious diseases. The firm develops and produces peptide-based antimicrobial products to treat infectious diseases. The company was founded by Michael and Elisabeth Lang in March 2014 and is headquartered in Bogart, GA. | Health Technology |
BioVaxys Technology Corp. | |
BioVaxys LLC
BioVaxys LLC BiotechnologyHealth Technology BioVaxys LLC is a clinical stage biotechnology company, which engages in the development of immunotherapeutic vaccines for antiviral and individualized cancer therapy. It focuses on multihaptenized autologous vaccine that will initially be developed and marketed for melanoma and ovarian cancer. The company was founded by James Passin, Kenneth Kovan and David Berd and is headquartered in New York, NY. | Health Technology |
Bingham Hill Ventures | |
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |